Carney triad

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:139411OMIM:604287D44.8
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Carney triad is an extremely rare syndrome characterized by the co-occurrence of three distinct tumor types: gastrointestinal stromal tumors (GISTs), pulmonary chondromas (benign cartilaginous tumors of the lung), and extra-adrenal paragangliomas (tumors arising from neural crest-derived cells). First described by J. Aidan Carney in 1977, the condition predominantly affects young women, with most cases presenting before the age of 35. The complete triad (all three tumor types) is present in only a minority of patients; most individuals develop two of the three tumors. Carney triad is distinct from Carney-Stratakis syndrome (dyad), which involves only GISTs and paragangliomas and has a known germline succinate dehydrogenase (SDH) subunit mutation with autosomal dominant inheritance. The body systems primarily affected include the gastrointestinal tract (most commonly the stomach, where GISTs cause bleeding, pain, or obstruction), the lungs (where chondromas are often discovered incidentally on imaging), and the autonomic nervous system (where paragangliomas may be functional, producing catecholamines and causing hypertension, palpitations, and sweating). Additional associated findings may include esophageal leiomyoma and adrenocortical adenoma. GISTs in Carney triad tend to be multifocal and may recur or metastasize, particularly to the liver and lymph nodes, though the clinical course is often indolent compared to sporadic GISTs. The etiology of Carney triad remains largely unknown. Unlike Carney-Stratakis syndrome, most cases of Carney triad are sporadic and do not follow a clear Mendelian inheritance pattern, though epigenetic alterations such as hypermethylation of the SDHC gene promoter have been identified in tumor tissue. Treatment is primarily surgical, involving resection of symptomatic or growing tumors. Imatinib and other tyrosine kinase inhibitors used for sporadic GISTs have shown limited efficacy in Carney triad-associated GISTs, which are typically wild-type for KIT and PDGFRA mutations. Long-term surveillance is essential due to the risk of metachronous tumor development and recurrence over many years.

Clinical phenotype terms— hover any for plain English:

PheochromocytomaHP:0002666ParagangliomaHP:0002668Adrenal overactivityHP:0002717Adrenocortical adenomaHP:0008256LeiomyosarcomaHP:0100243Mediastinal lymphadenopathyHP:0100721
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Childhood to adulthood

Can begin any time from childhood through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Carney triad.

View clinical trials →

No actively recruiting trials found for Carney triad at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Carney triad community →

Specialists

1 foundView all specialists →
LP
Laura C Hernández Ramírez, MD, PhD
Mexico City, Mexico City
Specialist

Rare Disease Specialist

PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Carney triad.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Carney triadForum →

No community posts yet. Be the first to share your experience with Carney triad.

Start the conversation →

Latest news about Carney triad

No recent news articles for Carney triad.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Carney triad

What is Carney triad?

Carney triad is an extremely rare syndrome characterized by the co-occurrence of three distinct tumor types: gastrointestinal stromal tumors (GISTs), pulmonary chondromas (benign cartilaginous tumors of the lung), and extra-adrenal paragangliomas (tumors arising from neural crest-derived cells). First described by J. Aidan Carney in 1977, the condition predominantly affects young women, with most cases presenting before the age of 35. The complete triad (all three tumor types) is present in only a minority of patients; most individuals develop two of the three tumors. Carney triad is distinct

How is Carney triad inherited?

Carney triad follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Carney triad typically begin?

Typical onset of Carney triad is childhood to adulthood. Age of onset can vary across affected individuals.

Which specialists treat Carney triad?

1 specialists and care centers treating Carney triad are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.